OPK Opko Health Inc

$1.41

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Opko Health Inc

OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.

Website: https://www.opko.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
944809
Address
4400 BISCAYNE BLVD., MIAMI, FL, US
Valuation
Market Cap
$1.13B
P/E Ratio
nan
PEG Ratio
-2.87
Price to Book
0.82
Performance
EPS
$-0.08
Dividend Yield
—
Profit Margin
-7.46%
ROE
-3.86%
Technicals
50D MA
$1.68
200D MA
$1.55
52W High
$2.04
52W Low
$1.15
Fundamentals
Shares Outstanding
793M
Target Price
$3.99
Beta
1.79

OPK EPS Estimates vs Actual

● Estimated
● Actual

OPK News & Sentiment

Aug 08, 2025 • Motley Fool SOMEWHAT-BULLISH
Entera Bio Beats Q2 EPS Estimates
Entera Bio ( NASDAQ:ENTX ) , a clinical-stage biotech specializing in oral delivery of protein and peptide drugs, released its earnings for the second quarter of fiscal 2025 on August 8, 2025. The most notable news was a better-than-expected GAAP earnings per share of $0.06, compared to Wall ...
Aug 08, 2025 • Benzinga SOMEWHAT-BULLISH
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - Entera Bio ( NASDAQ:ENTX )
FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density ( BMD ) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment
Aug 08, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
JERUSALEM, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ: ENTX ) , a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.
Aug 07, 2025 • Motley Fool SOMEWHAT-BULLISH
OPKO Health ( OPK ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 31, 2025, at 4:30 p.m. ETNeed a quote from one of our analysts? Email pr@fool.comContinue reading ...
Aug 01, 2025 • Motley Fool NEUTRAL
Opko Health ( OPK ) Q2 Revenue Falls 14%
Opko Health ( NASDAQ:OPK ) , a diversified healthcare company operating in diagnostics and pharmaceuticals, released its second quarter 2025 results on July 31, 2025. The company reported a significant revenue miss, with total GAAP revenue at $156.8 million, compared to analyst expectations of ...
Aug 01, 2025 • Zacks Commentary NEUTRAL
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.
Sentiment Snapshot

Average Sentiment Score:

0.084
50 articles with scored sentiment

Overall Sentiment:

Neutral

OPK Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.02 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 13.7%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.10
  • Whisper: —
  • Surprise %: 110.0%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 66.7%
Aug 07, 2024
Jun 30, 2024 (Post market)
0.08 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 88.9%
May 07, 2024
Mar 31, 2024 (Post market)
-0.03 Surprise
  • Reported EPS: $-0.12
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: -33.3%
Feb 27, 2024
Dec 31, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 0.0%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.11
  • Estimate: $-0.10
  • Whisper: —
  • Surprise %: -10.0%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 57.1%
May 03, 2023
Mar 31, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.08
  • Whisper: —
  • Surprise %: 75.0%

Financials